Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FKEMF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $196,900
Award facts
- Contract value 100% obligated
- $196,899.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $196.9K by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. This firm fixed-price delivery order, with an ultimate completion date of October 9, 2025, carries no set-aside designation and represents a discrete fulfillment under DMS Pharmaceutical Group's broader relationship with DLA. The award will be performed at the company's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499.999 billion through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense medical supply requirements. Keytruda, an oncology therapeutic, exemplifies the specialized pharmaceutical portfolio that DMS Pharmaceutical Group routinely supplies to military health facilities nationwide. The contractor's established presence in the federal pharmaceutical supply chain, demonstrated through consistent contract awards across multiple therapeutic categories, positions it as a critical distributor for DOD healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FKEMF?
SPE2DB25FKEMF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FKEMF worth?
The government has obligated $196,900 on SPE2DB25FKEMF.
Is contract SPE2DB25FKEMF an order under another contract?
Yes. SPE2DB25FKEMF is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEMF competed?
The extent of competition for SPE2DB25FKEMF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award